Skip to main content

Advertisement

Log in

Comparative evaluation of anatomical and functional outcomes using brilliant blue G versus triamcinolone assisted ILM peeling in macular hole surgery in Indian population

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To compare anatomical and functional outcomes using brilliant blue G (BBG) vs triamcinolone acetonide (TA)-assisted ILM peeling in macular hole surgery (MHS).

Study design

Simple, comparative, retrospective, non-randomised, interventional single-centre study.

Methods

Ninety-four eyes of 94 patients with idiopathic macular holes (≥ stage 2) who underwent MHS at our centre were included. Patients with failed macular holes, post-traumatic macular holes, history of previous vitreoretinal surgery, high myopia (6 dioptres or more) or any other macular pathology potentially limiting visual acuity, such as diabetic retinopathy or age-related macular degeneration, were excluded. An OCT evaluation of hole status was followed by pars plana vitrectomy for each of these eyes. Those who underwent TA-assisted ILM peeling were considered as group 1 and those with BBG-assisted ILM peeling were considered as group 2. Primary outcome measures included anatomical hole closure and functional success in terms of change in visual acuity of ≥2 LogMAR lines. Various preoperative factors were also evaluated.

Results

Anatomical hole closure was achieved in 85 eyes (90.43%) and visual gain in 78 eyes (82.9%). Mean postoperative follow-up duration was 16.14 ± 1.95 months. No significant difference was found in anatomical and functional success between the two groups. Group 1 had a significantly higher incidence of postoperative glaucoma. Duration of symptoms of <12 months (p = 0.004) and preoperative visual acuity ≤1.0 LogMAR were related to anatomical success. However, greater visual gain was found in patients with chronic holes (≥12 months) (p = 0.046) and poor preoperative visual acuity (>1.0 LogMAR) (p = 0.001).

Conclusion

BBG-assisted ILM peeling offers an effective alternative to triamcinolone, with the added advantage of marked enhancement of vitreoretinal interface contrast with comparable hole closure rates and visual outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kelly NE, Wendel RT (1991) Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 109:654–659

    PubMed  CAS  Google Scholar 

  2. Kwok AK, Lai TY, Man-Chan W, Woo DC (2003) Indocyanine green assisted internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol 87:71–74

    Article  PubMed  CAS  Google Scholar 

  3. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD (1993) Vitreous surgery for macular holes. Ophthalmology 100:1671–1676

    PubMed  CAS  Google Scholar 

  4. Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A (2002) Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol 134:661–666

    Article  PubMed  Google Scholar 

  5. Smiddy WE, Feuer W, Cordahi G (2001) Internal limiting membrane peeling in macular hole surgery. Ophthalmology 108:1471–1476

    Article  PubMed  CAS  Google Scholar 

  6. Freeman WR, Azen SP, Kim JW, el-Haig W, Mishell DR, Bailey I (1997) Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol 115:11–21

    PubMed  CAS  Google Scholar 

  7. Ruby AJ, Williams DF, Grand MG, Thomas MA, Meredith TA, Boniuk I, Olk RJ (1994) Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 112:359–364

    PubMed  CAS  Google Scholar 

  8. Orellana J, Lieberman RM (1993) Stage III macular hole surgery. Br J Ophthalmol 77:555–558

    Article  PubMed  CAS  Google Scholar 

  9. Ryan EH Jr, Gilbert HD (1994) Results of surgical treatment of recent-onset full-thickness idiopathic macular holes. Arch Ophthalmol 112:1545–1553

    PubMed  Google Scholar 

  10. Brooks HL Jr (2000) Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 107:1939–1948

    Article  PubMed  Google Scholar 

  11. Mester V, Kuhn F (2000) Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol 129:769–777

    Article  PubMed  CAS  Google Scholar 

  12. Margherio RR, Margherio AR, Williams GA, Chow DR, Banach MJ (2000) Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes. Arch Ophthalmol 118:495–498

    PubMed  CAS  Google Scholar 

  13. Ando F, Sasano K, Ohba N, Hirose H, Yasui O (2004) Anatomic and visual outcome after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 137:609–614

    PubMed  Google Scholar 

  14. Morris R, Kuhn F, Witherspoon CD (1994) Hemorrhagic macular cysts. Ophthalmology 101:1

    PubMed  CAS  Google Scholar 

  15. Liesenhoff O, Messmer EM, Pulur A, Kampik A (1996) Surgical management of complete macular foramina. Ophthalmologe 93:655–659

    Article  PubMed  CAS  Google Scholar 

  16. Uemoto R, Yamamoto S, Aoki T, Tsukahara I, Yamamoto T, Takeuchi S (2002) Macular configuration determined by optical coherence tomography after idiopathic macular hole surgery with or without internal limiting membrane peeling. Br J Ophthalmol 86:1240–1242

    Article  PubMed  CAS  Google Scholar 

  17. Rodrigues EB, Meyer CH, Kroll P (2005) Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 243:291–293

    Article  PubMed  Google Scholar 

  18. Rodrigues EB, Penha FM, de Paula Fiod Costa E, Maia M, Dib E, Moraes M Jr, Meyer CH, Magalhaes O Jr, Melo GB, Stefano V, Dias AB, Farah ME (2010) Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery. Am J Ophthalmol 149:265–277

    Article  PubMed  CAS  Google Scholar 

  19. Rodrigues EB, Costa EF, Penha FM, Melo GB, Bottós J, Dib E, Furlani B, Lima VC, Maia M, Meyer CH, Höfling-Lima AL, Farah ME (2009) The use of vital dyes in ocular surgery. Surv Ophthalmol 54:576–617

    Article  PubMed  Google Scholar 

  20. Kumar A, Wagh VB, Prakash G, Nag TC, Prakash S et al (2005) Visual outcome and electron microscopic features of Indocyanine green-assisted internal limiting membrane peeling from macular hole of various etiologies. Indian J Ophthalmol 53:159–165

    Article  PubMed  Google Scholar 

  21. Kumar A, Prakash G, Singh RP (2002) Indocyanine green enhanced maculorrhexis in macular hole surgery. Indian J Ophthalmol 50:123–126

    PubMed  Google Scholar 

  22. Rezai KA, Farrokh-Siar L, Ernest JT, van Seventer GA (2004) Indocyanine green induces apoptosis in human retinal pigment epithelial cells. Am J Ophthalmol 137:931–933

    Article  PubMed  CAS  Google Scholar 

  23. Meyer CH (2008) Toxicity of indocyanine green in vitreoretinal surgery. Vital dyes in vitreoretinal surgery. Dev Ophthalmol 42:69–81, Basel, Karger

    Google Scholar 

  24. Meyer CH (2008) Current concepts of Trypan blue in chromovitrectomy. Vital dyes in vitreoretinal surgery. Dev Ophthalmol 42:91–100, Basel, Karger

    PubMed  Google Scholar 

  25. Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J (2003) Trypan blue staining of the internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol 87:216–219

    Article  PubMed  CAS  Google Scholar 

  26. Perrier M, Sebag M (2003) Epiretinal membrane surgery assisted by Trypan blue. Am J Ophthalmol 135:909–911

    Article  PubMed  Google Scholar 

  27. Teba FA, Mohr A, Eckardt C, Wong D, Kusaka S, Joondeph BC, Feron EJ, Stalmans P, Van Overdam K, Melles GR (2003) Trypan blue staining in vitreoretinal surgery. Ophthalmology 110:2409–2412

    Article  PubMed  Google Scholar 

  28. Veckeneer M, van Overdam K, Monzer J, Kobuch K, van Marle W, Spekreijse H, van Meurs J (2001) Ocular toxicity study of Trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 239:698–704

    Article  PubMed  CAS  Google Scholar 

  29. Jin Y, Uchida S, Yanagi Y, Aihara M, Araie M (2005) Neurotoxic effects of Trypan blue on rat retinal ganglion cells. Exp Eye Res 81:395–400

    Article  PubMed  CAS  Google Scholar 

  30. Rezai KA, Farrokh-Siar L, Gasyna EM, Ernest JT (2004) Trypan blue induces apoptosis in human retinal pigment epithelial cells. Am J Ophthalmol 138:492–495

    Article  PubMed  CAS  Google Scholar 

  31. Enaida H, Hisatomi T, Hata Y, Ueno A, Goto Y, Yamada T, Kubota T, Ishibashi T (2006) Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G assisted membrane peeling. Retina 26:631–636

    Article  PubMed  Google Scholar 

  32. Meyer CH (2008) Brilliant blue in vitreoretinal surgery. Vital dyes in vitreoretinal surgery. Dev Ophthalmol 42:115–125, Basel, Karger

    Google Scholar 

  33. Enaida H, Hisatomi T, Goto Y, Hata Y, Ueno A, Miura M, Kubota T, Ishibashi T (2006) Preclinical investigation of internal limiting membrane peeling and staining using intravitreal brilliant blue G. Retina 26:623–630

    Article  PubMed  Google Scholar 

  34. Tornambe PE, Poliner LS, Cohen RG (1998) Definition of macular hole surgery end points: elevated/open, flat/open, flat/closed. Retina 18:286–287

    Article  PubMed  CAS  Google Scholar 

  35. Kumagai K, Furukawa M, Ogino N, Uemura A, Demizu S, Larson E (2004) Vitreous surgery with and without internal limiting membrane peeling for macular hole repair. Retina 24:721–727

    Article  PubMed  Google Scholar 

  36. Abdelkader E, Lois N (2008) Internal limiting membrane peeling in vitreoretinal surgery. Surv Ophthalmol 53:368–396

    Article  PubMed  Google Scholar 

  37. Kwok AK, Lai TY, Wong VW (2005) Idiopathic macular hole surgery in Chinese patients: a randomised study to compare Indocyanine green-assisted internal limiting membrane peeling with no internal limiting membrane peeling. Hong Kong Med J 11:259–266

    PubMed  CAS  Google Scholar 

  38. Smiddy WE, Flynn HW Jr (2004) Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol 137:525–537

    Article  PubMed  CAS  Google Scholar 

  39. Kwok AK, Li WW, Pang CP, Lai TY, Yam GH, Chan NR, Lam DS (2001) Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 132:178–183

    Article  PubMed  CAS  Google Scholar 

  40. Yooh HS, Brooks HL, Capone A, L’Hernault NL, Grossniklaus HE (1996) Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 122:67–75

    PubMed  CAS  Google Scholar 

  41. Da Mata AP, Burk SE, Riemann CD, Rosa RH Jr, Snyder ME, Petersen MR, Foster RE (2001) Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 108:1187–1192

    Article  PubMed  Google Scholar 

  42. Nomoto H, Shiraga F, Yamaji H, Fukuda K, Baba T, Takasu I, Ohtsuki H (2008) Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results. Retina 28:427–432

    Article  PubMed  Google Scholar 

  43. Horio N, Horiguchi M, Yamamoto N (2005) Triamcinolone-assisted internal limiting membrane peeling during idiopathic macular hole surgery. Arch Ophthalmol 123:96–99

    Article  PubMed  Google Scholar 

  44. Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20:554–555

    Article  PubMed  CAS  Google Scholar 

  45. Shah GK, Rosenblatt BJ, Blinder KJ, Grand MG, Smith M (2005) Triamcinolone assisted internal membrane peeling. Retina 25:972–975

    Article  PubMed  Google Scholar 

  46. Shah GK, Rosenblatt BJ, Smith M (2004) Internal limiting membrane peeling using triamcinolone acetonide: histopathologic confirmation. Am J Ophthalmol 138:656–657

    Article  PubMed  CAS  Google Scholar 

  47. Park DW, Sipperley JO, Sneed SR, Dugel PU, Jacobsen J (1999) Macular hole surgery with internal limiting membrane peeling and intravitreous air. Ophthalmology 106:1392–1397

    Article  PubMed  CAS  Google Scholar 

  48. Funata M, Wendel RT, de la Cruz Z, Green WR (1992) Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 12:289–298

    Article  PubMed  CAS  Google Scholar 

  49. Kumar A, Sinha S, Gupta A (2010) Residual triamcinolone acetonide at macular hole after vitreous surgery. Indian J Ophthalmol 58:232–234

    Article  PubMed  Google Scholar 

  50. Fukukita M, Sasoh M, Matsubara H, Furuta M, Okawa C, Ito Y et al (2007) Triamcinolone acetonide remaining on the fovea after successful macular hole closure. Retina 27:122–123

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Atul Kumar.

Additional information

No financial support has been received by any author, and none of the authors have proprietary interest in the subject matter presented.

Authors have full control of all primary data, and they agree to allow Graefe's Archive for Clinical and Experimental Ophthalmology to review their data upon request.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, A., Gogia, V., Shah, V.M. et al. Comparative evaluation of anatomical and functional outcomes using brilliant blue G versus triamcinolone assisted ILM peeling in macular hole surgery in Indian population. Graefes Arch Clin Exp Ophthalmol 249, 987–995 (2011). https://doi.org/10.1007/s00417-010-1609-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-010-1609-1

Keywords

Navigation